3.74
前日終値:
$3.74
開ける:
$3.77
24時間の取引高:
1.08M
Relative Volume:
0.67
時価総額:
$517.18M
収益:
-
当期純損益:
$-45.44M
株価収益率:
-10.69
EPS:
-0.35
ネットキャッシュフロー:
$-42.28M
1週間 パフォーマンス:
-9.00%
1か月 パフォーマンス:
+1.08%
6か月 パフォーマンス:
+97.88%
1年 パフォーマンス:
+120.00%
Compass Therapeutics Inc Stock (CMPX) Company Profile
CMPX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
CMPX
Compass Therapeutics Inc
|
3.74 | 641.68M | 0 | -45.44M | -42.28M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-01 | 再開されました | Raymond James | Outperform |
| 2025-04-02 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2025-02-24 | 開始されました | Guggenheim | Buy |
| 2025-02-19 | 開始されました | Piper Sandler | Overweight |
| 2024-12-23 | 開始されました | D. Boral Capital | Buy |
| 2024-11-15 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-09-16 | アップグレード | Ladenburg Thalmann | Neutral → Buy |
| 2023-01-31 | 開始されました | Jefferies | Buy |
| 2023-01-27 | 開始されました | Stifel | Buy |
| 2022-05-23 | 再開されました | H.C. Wainwright | Buy |
| 2022-03-15 | 開始されました | Ladenburg Thalmann | Buy |
| 2022-01-19 | 開始されました | B. Riley Securities | Buy |
| 2021-12-22 | 開始されました | Raymond James | Outperform |
| 2021-12-20 | 開始されました | SVB Leerink | Outperform |
| 2021-12-15 | 開始されました | Wedbush | Outperform |
すべてを表示
Compass Therapeutics Inc (CMPX) 最新ニュース
Can Compass Therapeutics Inc. recover in the next quarter2025 Investor Takeaways & AI Driven Price Forecasts - newser.com
How to interpret RSI for Compass Therapeutics Inc. stockMarket Performance Summary & Fast Entry Momentum Alerts - newser.com
Compass Therapeutics to Participate in Upcoming November Investor Events - Yahoo Finance
How Compass Therapeutics Inc. stock performs in weak economyJuly 2025 Fed Impact & Community Shared Stock Ideas - newser.com
Institutional investors in Compass Therapeutics, Inc. (NASDAQ:CMPX) lost 9.0% last week but have reaped the benefits of longer-term growth - Yahoo Finance
Will Compass Therapeutics Inc. stock outperform growth indexesTrade Volume Report & Real-Time Sentiment Analysis - newser.com
How Compass Therapeutics Inc. stock performs in stagflationTrade Risk Assessment & Long Hold Capital Preservation Plans - newser.com
Is Compass Therapeutics Inc. stock recession proof2025 Growth vs Value & Consistent Income Trade Recommendations - newser.com
Why Compass Therapeutics Inc. stock is seen as undervaluedJuly 2025 Catalysts & Weekly Setup with ROI Potential - newser.com
Will Compass Therapeutics Inc. stock split attract more investorsMarket Risk Summary & Safe Swing Trade Setup Alerts - newser.com
How Compass Therapeutics Inc. stock trades before earningsJuly 2025 Breakouts & Reliable Trade Execution Plans - newser.com
Piper Sandler Remains Bullish on Compass Therapeutics (CMPX) - Insider Monkey
14 Stocks Under $5 with Highest Upside Potential - Insider Monkey
How to track smart money flows in Compass Therapeutics Inc.Quarterly Investment Review & Weekly High Potential Alerts - newser.com
Compass Therapeutics’ Phase 1 Study of CTX-8371: A Potential Game-Changer in Cancer Treatment - TipRanks
Compass Therapeutics Inc (CMPX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):